Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
3.65 Down 0.01(0.27%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:3.66
Open:3.66
Bid:3.25 x 5000
Ask:3.70 x 500
1y Target Est:6.50
Beta:2.1
Earnings Date:Aug 10 - Aug 14 (Est.)
Day's Range:3.52 - 3.68
52wk Range:1.94 - 5.48
Volume:919,728
Avg Vol (3m):1,662,630
Market Cap:430.24M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRADown 0.27%430.24M
DVAXUp 1.42%690.67M
PFEDown 0.95%205.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,148.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback